Literature DB >> 32336349

Exon Definition Facilitates Reliable Control of Alternative Splicing in the RON Proto-Oncogene.

Mihaela Enculescu1, Simon Braun2, Samarth Thonta Setty3, Anke Busch2, Kathi Zarnack3, Julian König4, Stefan Legewie5.   

Abstract

Alternative splicing is a key step in eukaryotic gene expression that allows for the production of multiple transcript and protein isoforms from the same gene. Even though splicing is perturbed in many diseases, we currently lack insights into regulatory mechanisms promoting its precision and efficiency. We analyze high-throughput mutagenesis data obtained for an alternatively spliced exon in the proto-oncogene RON and determine the functional units that control this splicing event. Using mathematical modeling of distinct splicing mechanisms, we show that alternative splicing is based in RON on a so-called "exon definition" mechanism. Here, the recognition of the adjacent exons by the spliceosome is required for removal of an intron. We use our model to analyze the differences between the exon and intron definition scenarios and find that exon definition prevents the accumulation of deleterious, partially spliced retention products during alternative splicing regulation. Furthermore, it modularizes splicing control, as multiple regulatory inputs are integrated into a common net input, irrespective of the location and nature of the corresponding cis-regulatory elements in the pre-messenger RNA. Our analysis suggests that exon definition promotes robust and reliable splicing outcomes in RON splicing.
Copyright © 2020 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32336349      PMCID: PMC7175406          DOI: 10.1016/j.bpj.2020.02.022

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  50 in total

Review 1.  Alternative mRNA splicing in cancer immunotherapy.

Authors:  Luke Frankiw; David Baltimore; Guideng Li
Journal:  Nat Rev Immunol       Date:  2019-07-30       Impact factor: 53.106

2.  The RNA polymerase II C-terminal domain promotes splicing activation through recruitment of a U2AF65-Prp19 complex.

Authors:  Charles J David; Alex R Boyne; Scott R Millhouse; James L Manley
Journal:  Genes Dev       Date:  2011-05-01       Impact factor: 11.361

3.  View from an mRNP: The Roles of SR Proteins in Assembly, Maturation and Turnover.

Authors:  Marius Wegener; Michaela Müller-McNicoll
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 4.  More than a messenger: Alternative splicing as a therapeutic target.

Authors:  A J Black; J R Gamarra; J Giudice
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-02       Impact factor: 4.490

5.  Splicing of Nascent RNA Coincides with Intron Exit from RNA Polymerase II.

Authors:  Fernando Carrillo Oesterreich; Lydia Herzel; Korinna Straube; Katja Hujer; Jonathon Howard; Karla M Neugebauer
Journal:  Cell       Date:  2016-03-24       Impact factor: 41.582

6.  Splicing Kinetics and Coordination Revealed by Direct Nascent RNA Sequencing through Nanopores.

Authors:  Heather L Drexler; Karine Choquet; L Stirling Churchman
Journal:  Mol Cell       Date:  2019-12-12       Impact factor: 17.970

7.  Real-time imaging of cotranscriptional splicing reveals a kinetic model that reduces noise: implications for alternative splicing regulation.

Authors:  Ute Schmidt; Eugenia Basyuk; Marie-Cécile Robert; Minoru Yoshida; Jean-Philippe Villemin; Didier Auboeuf; Stuart Aitken; Edouard Bertrand
Journal:  J Cell Biol       Date:  2011-05-30       Impact factor: 10.539

8.  Widespread intra-dependencies in the removal of introns from human transcripts.

Authors:  Seong Won Kim; Allison J Taggart; Claire Heintzelman; Kamil J Cygan; Caitlin G Hull; Jing Wang; Barsha Shrestha; William G Fairbrother
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

Review 9.  Aberrant alternative splicing in breast cancer.

Authors:  Quan Yang; Jinyao Zhao; Wenjing Zhang; Dan Chen; Yang Wang
Journal:  J Mol Cell Biol       Date:  2019-10-25       Impact factor: 6.216

10.  In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactors.

Authors:  F X Reymond Sutandy; Stefanie Ebersberger; Lu Huang; Anke Busch; Maximilian Bach; Hyun-Seo Kang; Jörg Fallmann; Daniel Maticzka; Rolf Backofen; Peter F Stadler; Kathi Zarnack; Michael Sattler; Stefan Legewie; Julian König
Journal:  Genome Res       Date:  2018-04-11       Impact factor: 9.043

View more
  3 in total

1.  Splice site proximity influences alternative exon definition.

Authors:  Francisco Carranza; Hossein Shenasa; Klemens J Hertel
Journal:  RNA Biol       Date:  2022-01       Impact factor: 4.766

2.  High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance.

Authors:  Mariela Cortés-López; Laura Schulz; Mihaela Enculescu; Claudia Paret; Bea Spiekermann; Mathieu Quesnel-Vallières; Manuel Torres-Diz; Sebastian Unic; Anke Busch; Anna Orekhova; Monika Kuban; Mikhail Mesitov; Miriam M Mulorz; Rawan Shraim; Fridolin Kielisch; Jörg Faber; Yoseph Barash; Andrei Thomas-Tikhonenko; Kathi Zarnack; Stefan Legewie; Julian König
Journal:  Nat Commun       Date:  2022-09-22       Impact factor: 17.694

Review 3.  Dynamic mRNP Remodeling in Response to Internal and External Stimuli.

Authors:  Kathi Zarnack; Sureshkumar Balasubramanian; Michael P Gantier; Vladislav Kunetsky; Michael Kracht; M Lienhard Schmitz; Katja Sträßer
Journal:  Biomolecules       Date:  2020-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.